论文信息 - The use of a recombinant lentiviral vector for ex vivo gene transfer into the rat CNS

The use of a recombinant lentiviral vector for ex vivo gene transfer into the rat CNS

A major obstacle in ex vivo gene transfer has been the loss of transgene expression soon after implantation of the grafted transduced cells. Recently, a lentiviral vector system has been developed which has proven to express high levels of transgenes in vivo after direct injection into the tissue. In this study, we have investigated the use of such a vector for ex vivo gene transfer to the brain. A number of neural cell types were found to be permissive to transduction by the lentiviral vector in vitro and a majority of them expressed the transgene after transplantation to the rat brain. Transgene expression was detected up to 8 weeks post-grafting. These findings suggest that recombinant lentiviral vectors may be used for further development of ex vivo gene therapy protocols to the CNS.

[1] S. Dunnett,et al. Neural transplantation methods , 2000 .

[2] G. Felsenfeld,et al. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. , 1998, Genes & development.

[3] E. Snyder,et al. The Use of Nonneuronal Cells for Gene Delivery , 1997, Neurobiology of Disease.

[4] R. Mulligan,et al. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5] Scott R. Whittemore,et al. Target regulation of neuronal differentiation in a temperature-sensitive cell line derived from medullary raphe , 1993, Brain Research.

[6] R. Mulligan,et al. The basic science of gene therapy. , 1993, Science.

[7] Miles G. Cunningham,et al. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain , 1991, Cell.

[8] C. Cepko,et al. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. , 1990, Journal of neurobiology.